| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/27/2002 | CA2444356A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant |
| 12/26/2002 | US20020198571 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 12/26/2002 | US20020198570 Apparatus for indirectly stimulating the vagus nerve with an electrical field |
| 12/26/2002 | US20020198567 Electro-endocytotic therapy as a treatment modality of cancer |
| 12/26/2002 | US20020198510 Method for nasal application of a medicinal substance |
| 12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 12/26/2002 | US20020198264 Potentiating toxicity of 1,3-bis(chloroethyl)2-nitrosourea |
| 12/26/2002 | US20020198250 Pyrrolidine derivative hair growth compositions and uses |
| 12/26/2002 | US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells |
| 12/26/2002 | US20020198234 Identifying a patient suffering from fatigue arising from oncological condition, and administering to the patient a therapeutically effective amount of D-threo-methylphenidate free of 1-threo isomer |
| 12/26/2002 | US20020198226 Administration of an opioid analgesic agent(such as morphine, codeine, methadone and fentanyl) and a compound that binds to the SS1 or SS2 subunit of a sodium channel , such as tetrodotoxin and saxitonxin and derivatives |
| 12/26/2002 | US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 12/26/2002 | US20020198211 cDNA for human methylenetetrahydrofolate reductase and uses thereof |
| 12/26/2002 | US20020198210 Alpha-2-adrenergic agonist/fatty acid compositions |
| 12/26/2002 | US20020198201 Administering (R)-2-(2,6-dibromo-4-(9-bromo-2,3-dimethyl-naphtho(2,3-b)thiophen-4-yl) -phenoxy)-3-phenyl-propionic acid to lower free fatty acid blood levels in diabetic mammals |
| 12/26/2002 | US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis |
| 12/26/2002 | US20020198192 A therapeutic formulation comprising a topically acceptable non-solid vehicle and carbamazepine for treating psoriasis skin disorder; gels, creams, ointments, lotions, liquids, and suspensions |
| 12/26/2002 | US20020198187 Method of treating sexual disturbances |
| 12/26/2002 | US20020198179 An estrogen or prodrug micture for reducing or eliminating the incidence of hot flashes and menopausal symptoms, while decreasing the risk of acquiring breast or endometrial cancer, inhibiting the development of osteoporosis |
| 12/26/2002 | US20020198173 Viricides for treating HIV and hepatitis virus |
| 12/26/2002 | US20020198172 Administering a first dose of an effective amount of citicoline or a salt for the treatment of multiple sclerosis and amyotrophic lateral sclerosis |
| 12/26/2002 | US20020198170 Formulations of adenosine a1 agonists |
| 12/26/2002 | US20020198165 Nucleic acids for the prevention and treatment of gastric ulcers |
| 12/26/2002 | US20020198160 Compositions and methods for enhancing the bioavailability of pharmaceutical agents |
| 12/26/2002 | US20020198155 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders |
| 12/26/2002 | US20020198154 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 12/26/2002 | US20020198153 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent |
| 12/26/2002 | US20020198152 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 12/26/2002 | US20020198136 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc. |
| 12/26/2002 | US20020197737 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 12/26/2002 | US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression |
| 12/26/2002 | US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 12/26/2002 | US20020197633 Nucleotide sequence for use in the detection and analysis of gene expression associated with age resistance |
| 12/26/2002 | US20020197602 Nucleic acid sequences and proteins associated with aging |
| 12/26/2002 | US20020197598 Two hybrid assay that detects hiv-1 reverse transcriptase dimerization |
| 12/26/2002 | US20020197596 Phosphoprotein target for insulin and its antagonists |
| 12/26/2002 | US20020197330 Method of dietary supplementation |
| 12/26/2002 | US20020197313 Unit dosage forms for the treatment of herpes simplex |
| 12/26/2002 | US20020197306 Cationic lipid compositions targeting angiogenic endothelial cells |
| 12/26/2002 | US20020197298 Interior core in well containing active materials; aperture to exterior |
| 12/26/2002 | US20020197288 Topical applying; mixture of fibers and ubiquinone |
| 12/26/2002 | US20020197277 Cell culture system for synthesis of infectious hepatitis C virus |
| 12/26/2002 | US20020197256 Combination therapy |
| 12/26/2002 | US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 12/26/2002 | US20020197245 Antitumour compositions containing taxane derivatives |
| 12/26/2002 | US20020197235 Method for short-term and long-term drug dosimetry |
| 12/26/2002 | US20020197233 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 12/26/2002 | CA2391588A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one anti-inflammatory compound |
| 12/26/2002 | CA2391585A1 Cosmetic or dermatological composition including an association between a compound of the n-acylamino amides family and at least one matrix metalloproteinase inhibitor |
| 12/26/2002 | CA2391580A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one antifungal agent or at least one antibacterial agent |
| 12/26/2002 | CA2391574A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one muscle relaxant agent |
| 12/26/2002 | CA2391568A1 Collapsin response mediator protein-1 |
| 12/25/2002 | CN1387571A Mammalian cytokines, related reagents and methods |
| 12/25/2002 | CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 12/25/2002 | CN1387513A Positive modulators of nicotinic receptor agonists |
| 12/25/2002 | CN1387512A Positive modulators for nicotinic receptor agonists |
| 12/25/2002 | CN1387450A Use of dopamine-D3 receptor agonists for therapy of salt-dependent hypertension |
| 12/25/2002 | CN1387441A Use of nitric oxide for treatment of airway constriction |
| 12/25/2002 | CN1387438A 联合化学疗法 Combined chemotherapy |
| 12/25/2002 | CN1387437A 治疗用途 Therapeutic use |
| 12/25/2002 | CN1387436A Preventive and therapeutic agents for eye diseases |
| 12/25/2002 | CN1387434A Synergistic combinations of NK1 receptor antagonist and GABA structural analog |
| 12/25/2002 | CN1387433A Method for administering phosphodiesterase 4 inhibitor |
| 12/25/2002 | CN1387432A Methods of sing rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfnction |
| 12/25/2002 | CN1387404A Method and compositions for treating pulmonary diseases |
| 12/25/2002 | CN1386505A Application of Na-ion channel blocker and opium antalgesic in preparing synergic antalgic medicine for mammal |
| 12/25/2002 | CN1386503A Combined therapy for treating alcoholism and addiction of alcohol |
| 12/25/2002 | CN1096855C Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof |
| 12/25/2002 | CN1096854C GABA-ergic modulation of eye growth |
| 12/25/2002 | CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| 12/25/2002 | CN1096834C Flavonol contg. food supplements |
| 12/24/2002 | US6498188 Administrating an n-chlorophenylcarbamate or an n-chloro-phenylthiocarbamate in combination with potentiator and/or chemotherapeutic agent |
| 12/24/2002 | US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy |
| 12/24/2002 | US6498178 Inhibitors of IMPDH enzyme |
| 12/24/2002 | US6498173 Treatment of diseases based on acute or chronic obstruction of vessels and/or bronchi and/or inflammation |
| 12/24/2002 | US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis |
| 12/24/2002 | US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 12/24/2002 | US6498154 Cyclic regimens using quinazolinone and benzoxazine derivatives |
| 12/24/2002 | US6498152 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 12/24/2002 | US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors |
| 12/24/2002 | US6498143 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 12/24/2002 | US6498142 Osteogenic protein-1 (op-1) and other members of the op-1 subfamily of the tgf-.beta. superfamily of growth factors |
| 12/24/2002 | US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof |
| 12/24/2002 | US6497949 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 12/24/2002 | US6497906 Anticholesterol, reduced menstrual bleeding |
| 12/24/2002 | US6497904 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent |
| 12/24/2002 | US6497699 Hybrid neuroprosthesis for the treatment of brain disorders |
| 12/24/2002 | CA2086264C Surface complexed lymphotoxin |
| 12/20/2002 | WO2002000259A1 Remedial agent for anxiety neurosis or depression and piperazine derivative |
| 12/20/2002 | CA2413506A1 Remedial agent for anxiety neurosis or depression and piperazine derivative |
| 12/19/2002 | WO2002101392A2 Methods for treating disorders of the nervous and reproductive systems |
| 12/19/2002 | WO2002101385A1 In vivo bioreactors |
| 12/19/2002 | WO2002101357A2 Molecular signatures of commonly fatal carcinomas |
| 12/19/2002 | WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 12/19/2002 | WO2002101009A2 Structural and cytoskeleton-associated proteins |
| 12/19/2002 | WO2002101008A2 Intracellular signaling molecules |
| 12/19/2002 | WO2002101005A2 A g-protein coupled receptor and uses therefor |
| 12/19/2002 | WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein |
| 12/19/2002 | WO2002100890A2 Respiratory syncytial virus |
| 12/19/2002 | WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |